Yuichi Matsuno

Yuichi Matsuno

Auto-generated profile, based on publicly available information

Yuichi Matsuno

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2019 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
YMYuichi Matsuno
Yuichi Matsuno
AHAtsushi Hirano
Atsushi Hirano
TTTakehiro Torisu
Takehiro Torisu
YOYasuharu Okamoto
Yasuharu Okamoto
YFYuta Fuyuno
Yuta Fuyuno
MEMotohiro Esaki
Motohiro Esaki

30 April 2022 in Intestinal Research
Verified
Journal Article
Open access
PDF file
YMYuichi Matsuno
Yuichi Matsuno
TTTakehiro Torisu
Takehiro Torisu
JUJunji Umeno
Junji Umeno
HSHiroki Shibata
Hiroki Shibata
AHAtsushi Hirano
Atsushi Hirano
TKTakanari Kitazono
Takanari Kitazono
Background/Aims: Recent studies suggested a favorable effect of indigo naturalis (IN) in inducing remission for refractory ulcerative colitis (UC), however, the maintenance effect of IN for patients with UC remains unknown. Therefore, we conducted a prospective uncontrolled open-label study to analyze the efficacy and safety of IN for patients with UC.Methods: Patients with moderate to severe active UC (clinical activity index [CAI] ≥ 8) took 2 g/day of IN for 52 weeks. CAI at weeks 0, 4, 8, and 52 and Mayo endoscopic subscore (MES) and Geboes score (GS) at weeks 0, 4, and 52 were assessed. Clinical remission (CAI ≤ 4), mucosal healing (MES ≤ 1), and histological healing (GS ≤ 1) rates at each assessment were evaluated. Overall adverse events (AEs) during study period were also evaluated. The impact of IN on mucosal microbial composition was assessed using 16S ribosomal RNA gene sequences.Results: Thirty-three patients were enrolled. The rates of clinical remission at weeks 4, 8, and 52 were 67%, 76%, and 73%, respectively. The rates of mucosal healing at weeks 4 and 52 were 48% and 70%, respectively. AEs occurred in 17 patients (51.5%) during follow-up. Four patients (12.1%) showed severe AEs, among whom 3 manifested acute colitis. No significant alteration in the mucosal microbial composition was observed with IN treatment.Conclusions: One-year treatment of moderate to severe UC with IN was effective. IN might be a promising therapeutic option for maintaining remission in UC, although the relatively high rate of AEs should be considered.

1 August 2018 in Gastroenterology
Verified
Journal Article
Open access
PDF file
YMYuichi Matsuno
Yuichi Matsuno
AHAtsushi Hirano
Atsushi Hirano
MEMotohiro Esaki
Motohiro Esaki
We read with great interest the recent article by Naganuma et al.1 x 1 Naganuma, M. et al. Gastroenterology. 2018; 154: 935–947 Abstract | Full Text | Full Text PDF | PubMed | Scopus (23) | Google Scholar See all References The authors showed a significant effect of indigo naturalis in treating patients with ulcerative colitis (UC) in a randomized, placebo-controlled trial. In their study, patients were randomly assigned to groups given a daily dose of 0.5, 1.0, or 2.0 g of indigo naturalis or placebo for 8 weeks. The proportion of patients with a clinical response at week 8 was significantly higher in the 0.5-g indigo naturalis group (69.6%; P = .0002), 1.0-g indigo naturalis group (75.0%; P = .0001), and 2.0-g indigo naturalis group (81.0%; P < .0001) than in the placebo group (13.6%).

1 January 2022
Verified
Journal Article
Closed access
AHAkira Harada
Akira Harada
JUJunji Umeno
Junji Umeno
SMShinji Morisaki
Shinji Morisaki
TSTakuto Saiki
Takuto Saiki
YTyoshiaki taniguchi
yoshiaki taniguchi
HSHiroshi Suekane
Hiroshi Suekane

27 November 2023 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
AYAkihito Yokote
Akihito Yokote
NINoriyuki Imazu
Noriyuki Imazu
JUJunji Umeno
Junji Umeno
KKKeisuke Kawasaki
Keisuke Kawasaki
SFShin Fujioka
Shin Fujioka
TTTakehiro Torisu
Takehiro Torisu